Polfa Tarchomin S.A. Logo

Polfa Tarchomin S.A.

We produce over 50 drugs in almost 120 different dosage forms and strength. We are producing Active Pharmaceutical Ingredients (API), that have been used further to produce solid dosage forms of drugs. We are lunching second stage of investment in the modern oncological and immunosuppressive pharmaceuticals plant. We are proud especially because the congress, which took place between the 11th and 13th of December, was the most important academic and training event in Polish psychiatry in the last year. Our production capacity is 65 million of pack per year (tablets and capsules). Our product have broad usage in the public healthcare system. Our product have been used by the doctors to heal patients during the different parts of the therapy. The building will include a laboratory area for quality control, dedicated to product testing and a laboratory area for the R&D department.

Quick overview

Warsaw, Poland

Founded in 1823

1001-5000 Employees

Additional information

Working industry

Pharmaceuticals

Type of company

Manufacturer

Ownership structure

Public Company

Locations

1 Headquarter

Number of products

10 Products

Specialised areas

Antibiotics, insulin, Medicine, CNS, Pharmaceuticals

Products & services of Polfa Tarchomin S.A.

Polfa Tarchomin S.A. offers a wide range of products and services

Product: The New Production Department of Sterile Forms “Ampoule Facility” - Polfa Tarchomin

Product

The New Production Department of Sterile Forms “Ampoule Facility” - Polfa Tarchomin

Go to product >

Product: Tonasen – a new product in our offer, 26.09.2013 - Polfa Tarchomin

Product

Tonasen – a new product in our offer, 26.09.2013 - Polfa Tarchomin

Go to product >

Product: OSŁONIK MAX Junior - Polfa Tarchomin

Product

OSŁONIK MAX Junior - Polfa Tarchomin

Go to product >

Product: ZINADERMIN - Polfa Tarchomin

Product

ZINADERMIN - Polfa Tarchomin

Go to product >

Product: GOLDisept - Polfa Tarchomin

Product

GOLDisept - Polfa Tarchomin

Go to product >

Product: MICONAL - Polfa Tarchomin

Product

MICONAL - Polfa Tarchomin

Go to product >

Product: OSŁONIK MAX EXTRA - Polfa Tarchomin

Product

OSŁONIK MAX EXTRA - Polfa Tarchomin

Go to product >

Product: POLDERMIN HYDRO - Polfa Tarchomin

Product

POLDERMIN HYDRO - Polfa Tarchomin

Go to product >

Use Cases of Polfa Tarchomin S.A.

Get insights into the use cases of Polfa Tarchomin S.A.

UseCase: Projekt dofinansowany ze środków budżetu państwa lub państwowych funduszy celowych - Polfa Tarchomin

Use case

Projekt dofinansowany ze środków budżetu państwa lub państwowych funduszy celowych - Polfa Tarchomin

Informacja o dofinansowaniu udzielonym przez Agencję Badań Medycznych stanowiącym pomocą publiczną, udzieloną na podstawie Rozdziału 2 Rozporządzenia Ministra Zdrowia z dnia 5 września 2019 r. w sprawie warunków i trybu udzielania pomocy publicznej i pomocy de minimis za pośrednictwem Agencji Badań Medycznych Rodzaj dotacji budżetowej lub nazwa programu lub funduszu: KONKURS ABM/2022/4 NA OPRACOWANIE I ROZWÓJ

UseCase: Projekty dofinansowane z Funduszy Europejskich - Polfa Tarchomin

Use case

Projekty dofinansowane z Funduszy Europejskich - Polfa Tarchomin

Rozbudowa infrastruktury badawczo – rozwojowej laboratorium przeznaczonego do celu kontroli i certyfikacji wyrobów medycznych: środków ochrony indywidualnej oraz masek medycznych” Projekt p.n. „Rozbudowa infrastruktury badawczo – rozwojowej laboratorium przeznaczonego do celu kontroli i certyfikacji wyrobów medycznych: środków ochrony indywidualnej oraz masek medycznych” jest współfinansowany przez Unię Europejską ze środków Europejskiego Funduszu Rozwoju Regionalnego w ramach

Headquarter of Polfa Tarchomin S.A.

Polfa Tarchomin S.A. operates in 1 country around the world

City: Warsaw

State: Masovian Voivodeship

Country: Poland

Locations of Polfa Tarchomin S.A.

Get an overview of the locations of Polfa Tarchomin S.A.

Location

Country

State

City

Headquarter

Poland

Masovian Voivodeship

Warsaw

Frequently asked questions (FAQ) about Polfa Tarchomin S.A.

Some frequent questions that have been asked about Polfa Tarchomin S.A.

The company headquarter of Polfa Tarchomin S.A. is located in Warsaw, Masovian Voivodeship, Poland. It's worth noting, that the company may have more locations

As of the latest available information Polfa Tarchomin S.A. has around 1001-5000 employees worldwide.

Polfa Tarchomin S.A. was founded in 1823

The company Polfa Tarchomin S.A. has it's main focus in the industries of Pharmaceuticals

Competitors of Polfa Tarchomin S.A.

Check out some interesting alternative companies to Polfa Tarchomin S.A.

Polpharma API's Logo

Polpharma API

Starogard Gdański, Poland

1001-5000 Employees

-

We are proud of our 70 years of experience in supporting patients’ health with high quality APIs and becoming a leading European CDMO partner. API manufacturing is carried out in cGMP-compliant and FDA-approved multipurpose plant. Area dedicated to: POLPHARMA API PRODUCTION: 6,2 ha. Buildings dedicated to: Polpharma API production: 19.246 m2. API manufacturing is carried out in a cGMP-compliant and FDA-approved multipurpose plant. For over 80 years, trusted by patients, healthcare professionals, and business partners alike. A leading regional (CEE and CIS) manufacturer of pharmaceuticals and a leader in the Polish & Kazakhstan pharmaceutical market. Thanks to best-in-class industry talents and state-of-the-art technologies, we are able to design and deliver crucial products and solutions to address the biggest health challenges (an aging population, chronic diseases) and healthcare system problems (increasing healthcare costs, resource shortages).

Phytopharm Klęka S.A.'s Logo

Phytopharm Klęka S.A.

Nowe Miasto nad Wartą, Poland

251-500 Employees

1949

As we are constantly thinking about the future, we care for the environment by optimising energy consumption, segregating waste and starting pro-environmental projects. PHYTOPHARMAKON 2000 International Scientific Symposium is organised in Poznań to celebrate the 50th anniversary of the company. Our products are manufactured using the highest quality active ingredients with proven effectiveness and confirmed safety of use. We provide our customers with plant products intended for prevention and treatment. Consumers and pharmacists have trusted our products for many years. Many of the products rank top in their therapeutic categories. Therefore, we can safely say that it is one of the most advanced production facilities in the country. Pharmaceutical production starts — “Wytwórnia nr 11” (Factory No.

Medis Pharma B.V.'s Logo

Medis Pharma B.V.

Haarlem, Netherlands

- Employees

2001

Our comprehensive portfolio currently includes about 185 pharmaceutical products covering a broad range of therapeutic areas. We offer a wide range of dosage forms including immediate and modified release tablets and capsules, soluble and oro-dispersible tablets, soft gel capsules, nasal suspensions, ointments, gels, oral liquids and injectables. Our vast experience in launching new products together with our proven regulatory skills, enable us to achieve fast and successful results. We offer range of specialist oncology products and product formulations, mainly in the form of tablets, capsules and injections.

3d Pharmaceuticals's Logo

3d Pharmaceuticals

Viluppuram, India

- Employees

-

The company has set up modern manufacturing facilities conforming to international standards. This will provide exclusive production facilities and increased capacity to manufacture oral liquids, oral solids and Nutraceutical products, apart from giving us the additional capacity to undertake contract manufacturing. These units are built to regulatory specifications and will be able to produce and supply products to the global market. Having a strong quality conscious associate WHO-GMP & GMP manufacturing facilities for bulk and finished products spread across India, we are efficiently backed up by an a team of excellent technocrats & professionals. Continuously offering unique products and services that would give customers utmost satisfaction and constantly working on smart marketing to maintain the clarity of product positioning Our core strength has been in creating, maintaining and sustaining mutually beneficial business relations with the Top Indian Players including national as well as Multinational Organizations in India. To become an International corporation in the field of Pharmaceutical healthcare industry by offering innovative quality products at affordable cost to the mankind. We operate with effective governance; maintain reputation of transparency, openness, fairness, and high standards of ethical behavior. Our company has always concentrated on developing manufacturing infrastructure needed to efficiently produce the basket of products we are traditionally well placed in - and have continually put in effort & resources to develop our site in Pondicherry into a world class manufacturing complex.

Huayi Pharmaceuticals's Logo

Huayi Pharmaceuticals

Hefei, China

251-500 Employees

2006

We provide security and fulfillment to our employees and strive for excellence in all that we do. We are accountable to our shareholders and make a profit for them over the long term by innovating and investing. We are experienced in technology transfers and scale-up process for commercial production. We manufacture quality generic medicines on a contractual basis for EU and Chinese customers with competitive pricing. We are confident in our ability to work with customers from all countries from our facilities in China. We manufacture solid oral dosage forms for customers in Europe and are adding liquid forms in 2020. We were granted our EU Good Manufacturing Practice (GMP) Certificate in 2010 following inspection by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). Our dedication to manufacturing products of the highest quality can also be demonstrated by our facilities passing quality inspections by many customers including Novartis, Teva, Wockhardt, Genesis and Krka.

MediPharm a.s.'s Logo

MediPharm a.s.

Lipany, Slovakia

51-100 Employees

2011

We are committed to providing prompt and comprehensive assistance to meet your pharmaceutical business needs. We are also actively developing solid forms and production capabilities for both sterile and non-sterile drops. As part of our services, we offer contract manufacturing of final dosage forms for human use. Yes, we are fully compliant with all relevant regulatory standards, including European Union Good Manufacturing Practices (GMP) and other applicable guidelines. Our manufacturing process strictly adheres to the GMP principles, ensuring top-notch standards in all aspects of production. We specialize in the manufacturing of both dry and liquid injectable and infusible preparations, as well as product packaging and serialization. As the assignee of MedicProduct a.s., MediPharm a.s. With a rich heritage of 25 years in pharmaceutical production based in Lipany, Slovak Republic, MediPharm a.s.

Suitable topics for Polfa Tarchomin S.A.

Topics which have been searched by others and may be interesting for you: